File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Optimizing physician-encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study

TitleOptimizing physician-encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study
Authors
Keywordsdiabetes care
follow-up frequency
individualized care
type 2 diabetes
Issue Date2024
Citation
Diabetes, Obesity and Metabolism, 2024 How to Cite?
AbstractAim: To investigate whether the physician-encounter interval for patients with type 2 diabetes (T2D) can be optimized from 2–3 to 4–6 months among those with a calculated 10-year cardiovascular disease (CVD) risk score of less than 20% without compromising their long-term outcomes. Materials and Methods: Using territory-wide public electronic medical records in Hong Kong, we emulated a target trial to compare the effectiveness of the physician-encounter intervals of 4-6 versus 2-3 months for T2D patients without prior CVDs and with a predicted risk for CVDs of less than 20% (i.e. those patients not in the high-risk category). Propensity score matching was used to emulate the randomization of participants at baseline, where 42 154 matched individuals were included for analysis. The marginal structural model was applied to estimate the hazard ratio (HR) for CVD incidence and all-cause mortality, the incidence rate ratio of secondary and tertiary care utilization, as well as the between-group differences in HbA1c, blood pressure and cholesterol levels. Results: During a follow-up period of up to 12 (average: 5.1) years, there was no significantly increased risk of CVD in patients with physician-encounter intervals of 4-6 months compared with those patients with physician-encounter intervals of 2-3 months (HR [95% confidence interval {CI}]: 1.01 [0.90, 1.14]; standardized 10-year risk difference [95% CI]: −0.1% [−0.7%, 0.6%]), nor for all-cause mortality (HR: 1.00 [0.84, 1.20]; standardized 10-year risk difference: −0.1% [−0.5%, 0.3%]). Additionally, there was no observable difference in the utilization of secondary and tertiary care or key clinical parameters between these two follow-up frequencies. Conclusions: For T2D patients with a calculated 10-year CVD risk of less than 20%, the interval of regular physician encounters can be optimized from 2–3 to 4–6 months without compromising patients' long-term outcomes and saving substantial service resources in primary care.
Persistent Identifierhttp://hdl.handle.net/10722/346623
ISSN
2023 Impact Factor: 5.4
2023 SCImago Journal Rankings: 2.079

 

DC FieldValueLanguage
dc.contributor.authorXu, Wanchun-
dc.contributor.authorWang, Yuan-
dc.contributor.authorTanuseputro, Peter-
dc.contributor.authorLam, Cindy Lo Kuen-
dc.contributor.authorWan, Eric Yuk Fai-
dc.date.accessioned2024-09-17T04:12:09Z-
dc.date.available2024-09-17T04:12:09Z-
dc.date.issued2024-
dc.identifier.citationDiabetes, Obesity and Metabolism, 2024-
dc.identifier.issn1462-8902-
dc.identifier.urihttp://hdl.handle.net/10722/346623-
dc.description.abstractAim: To investigate whether the physician-encounter interval for patients with type 2 diabetes (T2D) can be optimized from 2–3 to 4–6 months among those with a calculated 10-year cardiovascular disease (CVD) risk score of less than 20% without compromising their long-term outcomes. Materials and Methods: Using territory-wide public electronic medical records in Hong Kong, we emulated a target trial to compare the effectiveness of the physician-encounter intervals of 4-6 versus 2-3 months for T2D patients without prior CVDs and with a predicted risk for CVDs of less than 20% (i.e. those patients not in the high-risk category). Propensity score matching was used to emulate the randomization of participants at baseline, where 42 154 matched individuals were included for analysis. The marginal structural model was applied to estimate the hazard ratio (HR) for CVD incidence and all-cause mortality, the incidence rate ratio of secondary and tertiary care utilization, as well as the between-group differences in HbA1c, blood pressure and cholesterol levels. Results: During a follow-up period of up to 12 (average: 5.1) years, there was no significantly increased risk of CVD in patients with physician-encounter intervals of 4-6 months compared with those patients with physician-encounter intervals of 2-3 months (HR [95% confidence interval {CI}]: 1.01 [0.90, 1.14]; standardized 10-year risk difference [95% CI]: −0.1% [−0.7%, 0.6%]), nor for all-cause mortality (HR: 1.00 [0.84, 1.20]; standardized 10-year risk difference: −0.1% [−0.5%, 0.3%]). Additionally, there was no observable difference in the utilization of secondary and tertiary care or key clinical parameters between these two follow-up frequencies. Conclusions: For T2D patients with a calculated 10-year CVD risk of less than 20%, the interval of regular physician encounters can be optimized from 2–3 to 4–6 months without compromising patients' long-term outcomes and saving substantial service resources in primary care.-
dc.languageeng-
dc.relation.ispartofDiabetes, Obesity and Metabolism-
dc.subjectdiabetes care-
dc.subjectfollow-up frequency-
dc.subjectindividualized care-
dc.subjecttype 2 diabetes-
dc.titleOptimizing physician-encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/dom.15899-
dc.identifier.scopuseid_2-s2.0-85202529710-
dc.identifier.eissn1463-1326-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats